WHY PATIENTS NEED YOU

The successful execution of clinical trials is essential to generate evidence to bring meaningful new medicines to patients. Every milestone—from study start-up, enrollment, conduct through completion—contributes to the quality, speed, and reliability of the evidence that informs treatment options and advances patient care.

Recruiting a patient population that reflects the people affected by the disease helps ensure that study results are relevant and informative to those who may ultimately use the medicine. This requires leaders with a focus on supporting clinical study teams to recruit efficiently and inclusively, balance representative enrollment with local and global regulatory requirements and resolve barriers to avoid delays to trial delivery. By enabling high-quality execution and timely enrollment, this role helps accelerate the development of new medicines for patients who need them.

WHAT YOU WILL ACHIEVE

In this role, you will serve as the dedicated U.S. Enrollment Clinical Study Team Lead for an assigned Accelerate priority Oncology study, leading a sub-team focused on delivering U.S. enrollment, key performance indicators, and emerging priorities. You will partner closely with the study Clinical Study Team Lead and core study team, with particular emphasis on the GSM, Recruitment Strategist, and Clinical Development Scientist, and engage additional partners such as the GDPL, FMD, U.S. CSOM, Site Care Partners, and other site-facing colleagues. Through regular dialogue and coordinated updates, you will help the team respond promptly and effectively to leadership and governance requests.

You will share accountability for U.S. enrollment performance with core study team members and facilitate development and implementation of an integrated U.S. plan from start-up through active recruitment. By encouraging open discussion and drawing on diverse functional and site-level perspectives, you will help the team test and align baseline site activation and recruitment plans, maintain one shared view of progress, connect U.S. delivery to the global plan, coordinate escalation efforts requiring site outreach, and address risks early through agreed pathways.

Success will be reflected in a collaborative operating rhythm, aligned plans, timely shared decisions, coordinated site outreach, disciplined follow-through, and trusted partnerships across the study team, ERMF, OSGT, R&D LT, MCI, and global recruitment colleagues.

HOW YOU WILL ACHIEVE IT

• Partner with the study team to advance U.S. enrollment performance and maintain an integrated U.S. enrollment strategy and action plan aligned with the global study strategy and the required U.S. enrollment contribution.
• Contribute to country and site feasibility questionnaire development and site selection decisions; Pressure test DVSO scenarios.
• Facilitate alignment across the core and extended study team on baseline plans for U.S. site activation and recruitment, including shared assumptions, milestones, dependencies, and accountabilities.
• Work with the colleagues aligned to deliver US enrollment to collectively test the U.S. site activation baseline plan, build visibility to progress, and agree early mitigations when milestones are at risk.
• Maintain a prioritized view of U.S. sites based on activation status, readiness, projected contribution, targeted representation, recruitment barriers, and actual performance.
• Bring Clinical, Site Care Partner, and FMD colleagues together to align site outreach, share insights and commitments, and ensure study-specific feedback informs coordinated next steps.
• Ensure priority sites have practical action plans that address patient identification, referral pathways, pre-screening, local barriers, and appropriate use of available recruitment tactics.
• Partner with Recruitment Strategistto prioritize contracting and increase appropriate use of available recruitment tactics, patient-matching capabilities, site support resources, and approved participant-facing materials in accordance with CMCD requirements. Open and willing to pilot novel strategies and tactics in an evolving landscape.
• Facilitate regular enrollment reviews that encourage candid discussion and provide one shared view of progress, risks, decisions, owners, due dates, and effectiveness checks across core, extended, governance, and site-facing colleagues.
• Monitor site activation, screening, screen failure, randomization, site productivity, targeted representation, and forecast-versus-actual performance; connect U.S. delivery to global recruitment plans and recommend corrective actions.
• Use the Enrollment Risk Management Framework to create a safe, transparent forum for surfacing site and study risks early, jointly developing mitigations, and seeking timely support through agreed escalation pathways when barriers extend beyond the team’s direct control.
• Serve as a collaborative connection point for leadership and governance engagement, including ERMF, OSGT, R&D LT, and MCI; partner with the study team to prepare concise materials, align messages, clarify decisions needed, and recommend practical actions.
• Build open, two-way feedback loops among governance partners, the study team, and site-facing colleagues; listen for differing perspectives, translate feedback into jointly owned actions, and share reusable lessons across U.S. oncology enrollment efforts.

QUALIFICATIONS

Must-Have

• Applicant must have a bachelor's degree with at least 8+ years of experience.
• Integrated U.S. enrollment strategy, aligned baseline activation and recruitment plans, and stakeholder map.
• Prioritized U.S. site view with activation status, targeted representation, site-level actions, outreach history, and study-specific feedback.
• One shared U.S. enrollment view connecting activation, recruitment, targeted representation, site risks, mitigations, and global plan impact.
• Action and decision log with accountable owners, due dates, and effectiveness checks.
• Executive-ready materials and coordinated responses for ERMF, OSGT, R&D LT, MCI, and other leadership requests.
• Documented lessons learned and handoff plan at the conclusion of the assignment. It might be helpful to frame this as a subteam with integrated communication and activities, because many of these functions ordinarily operate independently, and this may be a different way of working for some team members.

Nice-to-Have

• Master's degree with at least 7+ years of experience; OR a PhD with 5+ years of experience, OR a MD with 4+ years of experience.

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

OTHER JOB DETAILS

• Last Date to Apply for Job: October 26, 2026
• Additional Location Information: Global - Any Pfizer Site, USA - Any Pfizer Site
• Eligible for Relocation Package – NO
• Secondment 12 months
• This is a 50% Part time secondment.
• If you are currently in a driving position with a fleet vehicle and this secondment does not require driving as an essential function of the position for 12 months or longer, you will be required to turn in your fleet vehicle for the duration of the non-driving secondment.  Please refer to the Fleet Policy and Procedures document for more information.
• There will be no change to your current work location.
• Position is considered Flexible, and colleagues are expected to comply with Log In For Your Day (LIFYD) requirements at site location (e.g. about 2.5 days a week in office).

Relocation assistance may be available based on business needs and/or eligibility.

Candidates must be authorized to be employed in the U.S. by any employer.

U.S. work visa sponsorship (such as TN, O-1, H-1B, etc.) is not available for this role now or in the future.

To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.